M L 4 (Levothyroxine 25 mcg (0.025 mg))

Pill imprint M L 4 has been identified as Levothyroxine sodium 25 mcg (0.025 mg).

Levothyroxine is used in the treatment of hashimoto's disease; hypothyroidism, after thyroid removal; underactive thyroid; tsh suppression; thyroid suppression test (and more), and belongs to the drug class thyroid drugs. Studies show no risk during pregnancy. Levothyroxine 25 mcg (0.025 mg) is not subject to the Controlled Substances Act.

See also related documents.

Imprint Search

Images for M L 4

Levothyroxine sodium 25 mcg (0.025 mg) M L 4 Front
Levothyroxine sodium 25 mcg (0.025 mg) M L 4 Back
Levothyroxine sodium 25 mcg (0.025 mg) M L 4
Levothyroxine sodium 25 mcg (0.025 mg) M L 4
Levothyroxine sodium
Imprint:
M
L 4
Strength:
25 mcg (0.025 mg)
Color:
Orange
Size:
9.00 mm
Shape:
Capsule-shape
Availability:
Prescription only
Drug Class:
Thyroid drugs
Pregnancy Category:
A - Studies show no risk
CSA Schedule:
N - Not a controlled drug
Manufacturer:
Mylan Pharmaceuticals Inc.
National Drug Code (NDC):
00378-1800
Inactive Ingredients:
butylated hydroxyanisole
silicon dioxide
crospovidone
magnesium stearate
mannitol
microcrystalline cellulose
povidone
sodium lauryl sulfate
sucrose
FD&C Yellow No. 6
Other Manufacturers / Repackagers:
NDC CodeManufacturer / Repackager
51079-0444 UDL Laboratories Inc

Note: Inactive ingredients may vary.

View Details Print Page

Disclaimer: Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.

Copyright 2014 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.

Hide
(web2)